---
title: "Mahavir Advanced Remedies Ltd (111489) — Share Price, Financials & Analysis"
symbol: "111489"
company: "Mahavir Advanced Remedies Ltd"
canonical: "https://tapetide.com/stocks/111489"
sector: "Healthcare"
industry: "Pharmaceuticals & Biotechnology"
generated_at: "2026-09-13T18:50:54.224Z"
---

# Mahavir Advanced Remedies Ltd (111489)

Canonical page: https://tapetide.com/stocks/111489

## Company

- **Sector:** Healthcare
- **Industry:** Pharmaceuticals & Biotechnology
- **Macro Sector:** Healthcare
- **Stock Type:** EQUITY
- **Face Value:** ₹10
- **F&O Eligible:** No

## About

Mahavir Advanced Remedies Ltd is an India-based manufacturer and trading of tablet, liquid orals, capsules and ointments.

## Latest Price

## Key Insights

### Strengths

- Company is almost debt free.

### Weaknesses

- Stock is trading at 19.2 times its book value
- Company has a low return on equity of -2.33% over last 3 years.
- Working capital days have increased from 17,954 days to 30,258 days

## Growth Rates

| Metric | 1Y | 3Y |
| --- | --- | --- |
| net income growth | — | 69% |
| revenue growth | 82% | -25% |

## Financial Statements

### Quarterly Results

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2013 | Jun 2013 | Sep 2013 | Dec 2013 | Mar 2014 | Jun 2014 | Sep 2014 | Dec 2014 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Sales | 0.02 | 0.03 | 0.03 | 0.03 | 0.02 | 0.02 | 0.13 | 0.03 |
| Expenses | 0.08 | 0.02 | 0.01 | 0.01 | 0.15 | 0.01 | 0.02 | 0.02 |
| Operating Profit | -0.06 | 0.01 | 0.02 | 0.02 | -0.13 | 0.01 | 0.11 | 0.01 |
| OPM % | -300 | 33.33 | 66.67 | 66.67 | -650 | 50 | 84.62 | 33.33 |
| Other Income | 0 | 0 | -0.04 | 0 | 0.26 | 0 | 0 | 0 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit before tax | -0.06 | 0.01 | -0.02 | 0.02 | 0.13 | 0.01 | 0.11 | 0.01 |
| Tax % | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Profit | -0.06 | 0.01 | -0.02 | 0.02 | 0.13 | 0.01 | 0.11 | 0.01 |
| EPS in Rs | -0.05 | 0.01 | -0.02 | 0.02 | 0.11 | 0.01 | 0.1 | 0.01 |

### Profit & Loss

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2010 | Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | TTM |
| --- | --- | --- | --- | --- | --- | --- |
| Sales | 0.19 | 0.24 | 0.21 | 0.14 | 0.1 | 0.2 |
| Expenses | 0.21 | 0.25 | 0.53 | 0.3 | 0.18 | 0.2 |
| Operating Profit | -0.02 | -0.01 | -0.32 | -0.16 | -0.08 | 0 |
| OPM % | -10.53 | -4.17 | -152.38 | -114.29 | -80 | 0 |
| Other Income | 0 | 0 | 0 | 0.01 | 0.22 | 0.26 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 0.04 | 0.04 | 0 | 0 | 0 | 0 |
| Profit before tax | -0.06 | -0.05 | -0.32 | -0.15 | 0.14 | 0.26 |
| Tax % | 0 | 0 | 0 | 0 | 0 | — |
| Net Profit | -0.06 | -0.05 | -0.32 | -0.15 | 0.14 | 0.26 |
| EPS in Rs | — | — | — | -0.13 | 0.12 | 0.23 |
| Dividend Payout % | 0 | 0 | 0 | 0 | 0 | — |

### Balance Sheet

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2010 | Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Sep 2014 |
| --- | --- | --- | --- | --- | --- | --- |
| Equity Capital | 3.76 | 3.76 | 3.76 | 11.36 | 11.36 | 11.36 |
| Reserves | -2.82 | -2.87 | -3.11 | -2.71 | -2.57 | -2.45 |
| Borrowings | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Liabilities | 0.16 | 0.15 | 0.06 | 0 | 0.01 | 0.01 |
| Total Liabilities | 1.1 | 1.04 | 0.71 | 8.65 | 8.8 | 8.92 |
| Fixed Assets | 0.49 | 0.45 | 0 | 0 | 0 | 0 |
| CWIP | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 0.61 | 0.59 | 0.71 | 8.65 | 8.8 | 8.92 |
| Total Assets | 1.1 | 1.04 | 0.71 | 8.65 | 8.8 | 8.92 |

### Cash Flow

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2010 | Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 |
| --- | --- | --- | --- | --- | --- |
| Cash from Operating Activity | 0 | -0.01 | 0.01 | -8.17 | 0.48 |
| Cash from Investing Activity | 0 | 0 | 0.01 | 0 | 0 |
| Cash from Financing Activity | 0 | 0 | 0 | 8.16 | 0 |
| Net Cash Flow | 0 | -0.01 | 0.02 | -0.01 | 0.48 |
| Free Cash Flow | 0 | -0.01 | 0.12 | -8.17 | 0.48 |
| CFO/OP | 0 | 100 | -3 | 5106 | -600 |

### Ratios

| Item | Mar 2010 | Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 |
| --- | --- | --- | --- | --- | --- |
| Debtor Days | 211.32 | 167.29 | 191.19 | 0 | 0 |
| Inventory Days | 0 | 0 | — | — | — |
| Cash Conversion Cycle | 211.32 | 167.29 | 191.19 | 0 | 0 |
| Working Capital Days | 76.84 | 182.5 | 1077.62 | 22525.71 | 30258.5 |
| ROCE % | — | -5.46 | -41.56 | -3.23 | 1.61 |

## Filings & Documents

### Annual Reports

| Date | Document |
| --- | --- |
| from bse | [Annual Report 2014 from bse](http://www.bseindia.com/bseplus/AnnualReport/531689/5316890314.pdf) |
| from bse | [Annual Report 2013 from bse](https://www.bseindia.com/bseplus/AnnualReport//5316890313.pdf) |
| from bse | [Annual Report 2012 from bse](https://www.bseindia.com/bseplus/AnnualReport//5316890312.pdf) |
| from bse | [Annual Report 2011 from bse](https://www.bseindia.com/bseplus/AnnualReport//5316890311.PDF) |
| from bse | [Annual Report 2010 from bse](https://www.bseindia.com/bseplus/AnnualReport//5316890310.PDF) |

---

Provenance differs by section. Financial statements, shareholding and filings are as reported in company disclosures to NSE/BSE/SEBI. Price, volume and 52-week levels are exchange market data. Technical indicators are computed by Tapetide from daily closing prices. The Tapetide Score is Tapetide's own analysis. Analyst ratings are third-party estimates, not company statements. All figures are for research and information only and are not investment advice. Generated 2026-09-13T18:50:54.224Z.